World's Best Scientists 2026 revealed!

D-Index & Metrics

Economics and Finance

D-Index
53
Citations
9677
World Ranking
1197
National Ranking
135

Panos Kanavos publication distribution in Economics and Finance in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Economics and Finance in 2026. The highlighted bar marks where Panos Kanavos sits on this spectrum.

42–46 publications: 1 scientists 47–51 publications: 12 scientists 52–56 publications: 7 scientists 57–61 publications: 23 scientists 62–66 publications: 32 scientists 67–71 publications: 36 scientists 72–76 publications: 56 scientists 77–81 publications: 57 scientists 82–86 publications: 70 scientists 87–91 publications: 86 scientists 92–96 publications: 72 scientists 97–101 publications: 106 scientists 102–106 publications: 97 scientists 107–111 publications: 96 scientists 112–116 publications: 101 scientists 117–121 publications: 103 scientists 122–126 publications: 102 scientists 127–131 publications: 108 scientists 132–136 publications: 107 scientists 137–141 publications: 111 scientists 142–146 publications: 94 scientists 147–151 publications: 96 scientists 152–156 publications: 100 scientists 157–161 publications: 74 scientists 162–166 publications: 68 scientists 167–171 publications: 91 scientists 172–176 publications: 76 scientists 177–181 publications: 75 scientists 182–186 publications: 61 scientists 187–191 publications: 66 scientists 192–196 publications: 68 scientists 197–201 publications: 71 scientists 202–206 publications: 60 scientists 207–211 publications: 56 scientists 212–216 publications: 44 scientists 217–221 publications: 51 scientists 222–226 publications: 65 scientists 227–231 publications: 48 scientists 232–236 publications: 59 scientists 237–241 publications: 37 scientists 242–246 publications: 37 scientists 247–251 publications: 41 scientists 252–256 publications: 43 scientists 257–261 publications: 33 scientists 262–266 publications: 34 scientists 267–271 publications: 39 scientists 272–276 publications: 25 scientists 277–281 publications: 29 scientists 282–286 publications: 29 scientists 287–291 publications: 26 scientists 292–296 publications: 31 scientists 297–301 publications: 31 scientists 302–306 publications: 24 scientists 307–311 publications: 28 scientists 312–316 publications: 24 scientists 317–321 publications: 13 scientists 322–326 publications: 14 scientists 327–331 publications: 25 scientists 332–336 publications: 18 scientists 337–341 publications: 16 scientists 342–346 publications: 18 scientists 347–351 publications: 15 scientists 352–356 publications: 17 scientists 357–361 publications: 19 scientists 362–366 publications: 16 scientists 367–371 publications: 17 scientists 372–376 publications: 7 scientists 377–381 publications: 18 scientists 382–386 publications: 13 scientists 387–391 publications: 19 scientists 392–396 publications: 9 scientists 397–401 publications: 10 scientists 402–406 publications: 13 scientists 407–411 publications: 13 scientists 412–416 publications: 5 scientists 417–421 publications: 10 scientists 422–426 publications: 6 scientists 427–431 publications: 12 scientists 432–436 publications: 9 scientists 437–441 publications: 9 scientists 442–446 publications: 10 scientists 447–451 publications: 12 scientists 452–456 publications: 8 scientists 457–461 publications: 4 scientists 462–466 publications: 7 scientists 467–471 publications: 4 scientists 472–476 publications: 5 scientists 477–481 publications: 6 scientists 482–486 publications: 7 scientists 487–491 publications: 8 scientists 492–496 publications: 5 scientists 497–501 publications: 4 scientists 502–506 publications: 4 scientists 507–511 publications: 5 scientists 512–516 publications: 7 scientists 517–520 publications: 7 scientists 521+ publications: 99 scientists
42 publications 521+

This scientist: 272 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 521 publications or more.

Panos Kanavos D-index placement in Economics and Finance in 2026

The chart shows the D-index (discipline H-index) distribution of Economics and Finance scientists ranked by Research.com in 2026. The highlighted bar marks where Panos Kanavos sits on this spectrum.

30 D-Index: 126 scientists 31 D-Index: 147 scientists 32 D-Index: 157 scientists 33 D-Index: 178 scientists 34 D-Index: 171 scientists 35 D-Index: 141 scientists 36 D-Index: 132 scientists 37 D-Index: 129 scientists 38 D-Index: 130 scientists 39 D-Index: 120 scientists 40 D-Index: 117 scientists 41 D-Index: 113 scientists 42 D-Index: 114 scientists 43 D-Index: 97 scientists 44 D-Index: 115 scientists 45 D-Index: 86 scientists 46 D-Index: 78 scientists 47 D-Index: 83 scientists 48 D-Index: 62 scientists 49 D-Index: 74 scientists 50 D-Index: 50 scientists 51 D-Index: 66 scientists 52 D-Index: 69 scientists 53 D-Index: 55 scientists 54 D-Index: 67 scientists 55 D-Index: 61 scientists 56 D-Index: 62 scientists 57 D-Index: 45 scientists 58 D-Index: 34 scientists 59 D-Index: 47 scientists 60 D-Index: 46 scientists 61 D-Index: 36 scientists 62 D-Index: 37 scientists 63 D-Index: 56 scientists 64 D-Index: 50 scientists 65 D-Index: 32 scientists 66 D-Index: 28 scientists 67 D-Index: 30 scientists 68 D-Index: 24 scientists 69 D-Index: 25 scientists 70 D-Index: 22 scientists 71 D-Index: 21 scientists 72 D-Index: 26 scientists 73 D-Index: 24 scientists 74 D-Index: 23 scientists 75 D-Index: 12 scientists 76 D-Index: 14 scientists 77 D-Index: 15 scientists 78 D-Index: 15 scientists 79 D-Index: 17 scientists 80 D-Index: 17 scientists 81 D-Index: 11 scientists 82 D-Index: 10 scientists 83 D-Index: 16 scientists 84 D-Index: 11 scientists 85 D-Index: 5 scientists 86 D-Index: 9 scientists 87 D-Index: 13 scientists 88 D-Index: 9 scientists 89 D-Index: 7 scientists 90 D-Index: 6 scientists 91 D-Index: 4 scientists 92 D-Index: 8 scientists 93 D-Index: 10 scientists 94 D-Index: 11 scientists 95 D-Index: 6 scientists 96 D-Index: 4 scientists 97 D-Index: 4 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100 D-Index: 8 scientists 101+ D-Index: 100 scientists
30 D-Index 101+

This scientist: 53 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 101 D-Index or more.

Overview

Panos Kanavos is affiliated with the London School of Economics and Political Science in the United Kingdom. Their research primarily centers on the field of Economics, Econometrics, and Finance, with a significant focus on subfields such as Economics and Econometrics, General Health Professions, Immunology, Sociology and Political Science, and Genetics.

The main topics covered in their body of work include Health Systems, Economic Evaluations, and Quality of Life; Pharmaceutical Economics and Policy; Economic and Financial Impacts of Cancer; Biosimilars and Bioanalytical Methods; Healthcare cost, quality, and practices; Delphi Technique in Research; and Healthcare Policy and Management.

The scientist has contributed multiple papers across several prominent publication venues. The most frequent venues for their work include:

  • Value in Health
  • Zenodo (CERN European Organization for Nuclear Research)
  • London School of Economics and Political Science Research Online (London School of Economics and Political Science)
  • International Journal of Technology Assessment in Health Care
  • London School of Hygiene & Tropical Medicine

Among recent publications, the following papers stand out:

  • "Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries" (2021), published in PharmacoEconomics - Open
  • "Sin taxes and their effect on consumption, revenue generation and health improvement: a systematic literature review in Latin America" (2020), published in Health Policy and Planning
  • "Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland" (2022), published in Applied Health Economics and Health Policy
  • "Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA" (2022), published in Investigational New Drugs
  • "A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems" (2022), published in Frontiers in Medical Technology

Frequent co-authors collaborating with Panos Kanavos include:

  • Mackenzie Mills
  • Aris Angelis
  • Madeleine Haig
  • Mónica Duarte Oliveira
  • Carlos A. Bana e Costa

This extensive collaboration indicates active engagement in a network of researchers with overlapping interests in health economics and policy. The combination of topics and publication venues reflects a multidisciplinary approach spanning economics, health systems, and policy evaluation.

Best Publications

  • The rising burden of cancer in the developing world

    Panos Kanavos

  • Assessing the economic challenges posed by orphan drugs.

    Michael F. Drummond;David A. Wilson;Panos Kanavos;Peter Ubel

  • Socio-economic burden of rare diseases: A systematic review of cost of illness evidence

    Aris Angelis;David Tordrup;Panos Kanavos

  • Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

    Aris Angelis;Ansgar Lange;Panos Kanavos

  • Early chronic kidney disease: diagnosis, management and models of care

    Olivier J. Wouters;Donal J. O'Donoghue;James Ritchie;Panos G. Kanavos

  • Encouraging the use of generic medicines: implications for transition economies.

    Derek R King;Panos Kanavos

  • Ensuring value for money in health care: the role of health technology assessment in the European Union

    Corinna Sorenson;Michael Drummond;Panos Kanavos

  • Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework

    Aris Angelis;Panos Kanavos

  • Diabetes expenditure, burden of disease and management in 5 EU countries

    Panos Kanavos;Stacey van den Aardweg;Willemien Schurer

  • Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

    Olivier J. Wouters;Panos G. Kanavos;Martin McKEE

  • Competition in off‐Patent Drug Markets: Issues, Regulation and Evidence

    Panos Kanavos;Joan Costa-Font;Elizabeth Seeley

  • Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden.

    Alessandra Ferrario;Panos Kanavos

  • Centralized Drug Review Processes In Australia, Canada, New Zealand, And The United Kingdom

    Steven G. Morgan;Meghan McMahon;Craig Mitton;Elizabeth Roughead

  • Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review

    Andréa Dâmaso Bertoldi;Panos Kanavos;Giovanny Vinícius Araújo de França;Giovanny Vinícius Araújo de França;Andre Carraro

  • Pharmaceutical parallel trade in Europe: stakeholder and competition effects

    Panos Kanavos;Joan Costa-Font

  • Managed entry agreements for pharmaceuticals: the European experience

    Alessandra Ferrario;Panos Kanavos

  • The implementation of managed entry agreements in Central and Eastern Europe : findings and implications

    Alessandra Ferrario;Diāna Arāja;Tomasz Bochenek;Tarik Čatić

  • Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs

    Panos Kanavos;Alessandra Ferrario;Sotiris Vandoros;Gerard F. Anderson

  • Reference pricing for drugs: is it compatible with U.S. health care?

    Unknown

  • Differences in costs of and access to pharmaceutical products in the EU

    Panos Kanavos;Sotiris Vandoros;Rachel Irwin;Elena Nicod

  • Health care inequities in north India: Role of public sector in universalizing health care

    Shankar Prinja;Panos Kanavos;Rajesh Kumar

  • Do generics offer significant savings to the UK National Health Service

    Panos Kanavos

  • The Economic Impact of Pharmaceutical Parallel Trade in European Union Member States: A Stakeholder Analysis

    Panos Kanavos;Joan Costa-i-Font;Sherry Merkur;Marin Gemmill

  • Medical technology procurement in Europe: a cross-country comparison of current practice and policy

    Corinna Sorenson;Panos Kanavos

  • Measuring performance in off-patent drug markets: a methodological framework and empirical evidence from twelve EU Member States

    Panos Kanavos

Frequent Co-Authors

Joan Costa-Font
Joan Costa-Font London School of Economics and Political Science
Elias Mossialos
Elias Mossialos London School of Economics and Political Science
Michael Drummond
Michael Drummond University of York
Alistair McGuire
Alistair McGuire London School of Economics and Political Science
László Gulácsi
László Gulácsi Óbuda University
Zoltán Kaló
Zoltán Kaló Semmelweis University
Martin McKee
Martin McKee London School of Hygiene & Tropical Medicine
Martin Knapp
Martin Knapp London School of Economics and Political Science
Markus Cornberg
Markus Cornberg Hannover Medical School
Maria Inês Schmidt
Maria Inês Schmidt Federal University of Rio Grande do Sul

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Economics and Finance may find numerous online programs that support their academic and professional goals. Many opt for business-centered online degrees, including the affordable aacsb accredited online mba programs, offering broad management skills and leadership training. These programs are valuable for those aiming for upper-level business roles.

If your interests extend to hospitality or tourism sectors, consider enrolling in accelerated hospitality degree online programs. These help you fast-track your education while gaining industry-relevant knowledge.

For those passionate about people and organizational development, a master of human resource management offers specialized expertise in talent management, labor relations, and workplace strategy—skills highly valued by employers.

Communication skills are essential across all industries. Pursuing the cheapest online communications degree can empower you with abilities critical for careers in business, public relations, and finance alike.

Exploring these related online degrees can open multiple pathways, enhancing your employability and professional growth in today’s evolving job market.

Best Scientists Citing Panos Kanavos

Trending Scientists

Recently Published Articles